Literature DB >> 25523096

Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.

Xianjin Wu1, Rong Zeng2, Shaoke Wu2, Jixin Zhong3, Lawei Yang4, Junfa Xu5.   

Abstract

Breast cancer (BC) is the main factor that leads cause of cancer death in women worldwide. A class of small non-coding RNAs, microRNAs (miRNAs), has been widely studied in human cancers as crucial regulatory molecule. Recent studies indicate that a series of isomiRs can be yielded from a miRNA locus, and these physiological miRNA isoforms have versatile roles in miRNA biogenesis. Herein, we performed a comprehensive analysis of miRNAs at the miRNA and isomiR levels in BC using next-generation sequencing data from The Cancer Genome Atlas (TCGA). Abnormally expressed miRNA (miR-21, miR-221, miR-155, miR-30e and miR-25) and isomiR profiles could be obtained at the miRNA and isomiR levels, and similar biological roles could be detected. IsomiR expression profiles should be further concerned, and especially isomiRs are actual regulatory molecules in the miRNA-mRNA regulatory networks. The study provides a comprehensive expression analysis at the miRNA and isomiR levels in BC, which indicates biological roles of isomiRs.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast cancer (BC); Expression; IsomiR; MicroRNA (miRNA)

Mesh:

Substances:

Year:  2014        PMID: 25523096     DOI: 10.1016/j.gene.2014.12.030

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  19 in total

1.  A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.

Authors:  Masataka Nakano; Tatsuki Fukami; Saki Gotoh; Miki Nakajima
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

2.  Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.

Authors:  Tstutomu Kawaguchi; Li Yan; Qianya Qi; Xuan Peng; Stephen B Edge; Jessica Young; Song Yao; Song Liu; Eigo Otsuji; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2018-10-11       Impact factor: 5.344

3.  Promotional effect of microRNA-194 on breast cancer cells via targeting F-box/WD repeat-containing protein 7.

Authors:  Yaomin Chen; Haiyan Wei; Yu Liu; Shusen Zheng
Journal:  Oncol Lett       Date:  2018-01-23       Impact factor: 2.967

4.  MiR-223-3p targeting epithelial cell transforming sequence 2 oncogene inhibits the activity, apoptosis, invasion and migration of MDA-MB-468 breast cancer cells.

Authors:  Xiaorui Wang; Zhongsheng Tong; Hong Liu
Journal:  Onco Targets Ther       Date:  2019-09-18       Impact factor: 4.147

5.  miR-30e* is an independent subtype-specific prognostic marker in breast cancer.

Authors:  F D'Aiuto; M Callari; M Dugo; G Merlino; V Musella; P Miodini; B Paolini; V Cappelletti; M G Daidone
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

Review 6.  The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.

Authors:  Irene V Bijnsdorp; Martin E van Royen; Gerald W Verhaegh; Elena S Martens-Uzunova
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

7.  MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.

Authors:  Giuseppina Roscigno; Cristina Quintavalle; Elvira Donnarumma; Ilaria Puoti; Angel Diaz-Lagares; Margherita Iaboni; Danilo Fiore; Valentina Russo; Matilde Todaro; Giulia Romano; Renato Thomas; Giuseppina Cortino; Miriam Gaggianesi; Manel Esteller; Carlo M Croce; Gerolama Condorelli
Journal:  Oncotarget       Date:  2016-01-05

8.  Improved low-rank matrix recovery method for predicting miRNA-disease association.

Authors:  Li Peng; Manman Peng; Bo Liao; Guohua Huang; Wei Liang; Keqin Li
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

9.  Dicer partner protein tunes the length of miRNAs using base-mismatch in the pre-miRNA stem.

Authors:  Li Zhu; Suresh K Kandasamy; Ryuya Fukunaga
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

Review 10.  A myriad of roles of miR-25 in health and disease.

Authors:  Márta Sárközy; Zsuzsanna Kahán; Tamás Csont
Journal:  Oncotarget       Date:  2018-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.